NCT00002372View on ClinicalTrials.gov

A Study of 141W94 in Combination With Other Anti-HIV Drugs

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Indinavir sulfate

DRUG

Amprenavir

DRUG

Nelfinavir mesylate

DRUG

Saquinavir

Trial Locations (3)

27710

Univ of North Carolina at Chapel Hill / Duke Univ Med Ctr, Durham

92103

Univ of California / San Diego Treatment Ctr, San Diego

94109

ViRx Inc, San Francisco

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Glaxo Wellcome

INDUSTRY